Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 83

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 83
---
atives of Aadi’s management team presented to representatives of Kaken’s management team and Nomura regarding the FYARRO business and related matters.

Beginning on November 6, 2024, representatives of Aadi’s management team, Kaken Parent’s management team, Leerink Partners, Nomura, Wilson
Sonsini and McDermott Will & Emery LLP (“McDermott”), outside legal counsel to Kaken Parent, held a number of meetings via videoconference to discuss various due diligence matters, including legal, finance and accounting, and
intellectual property.

On November 7, 2024, representatives of Bidder B sent a proposed exclusivity agreement to representatives of Leerink
Partners, under which it was proposed that Aadi agree to exclusivity through December 6, 2024.

On November 8, 2024, after consulting with
members of Aadi’s management team, representatives of Leerink Partners informed representatives of Bidder B via telephone that, given the competitive process, Aadi was not in position to consider an exclusivity request from Bidder B without a
significant improvement in the offer and removal of certain closing conditions.

On November 12, 2024, representatives of Leerink Partners, Nomura,
Wilson Sonsini, and McDermott met via videoconference to discuss the Kaken October 17 Proposal and related transaction structure, particularly whether Kaken would consider acquiring the FYARRO business by purchasing Aadi Sub.

- 54 -

On November 13, 2024, at the direction of Aadi, representatives of Leerink Partners sent a draft stock
purchase agreement (“Divestiture Agreement”) to representatives of Nomura, under which Kaken would acquire the FYARRO business by purchasing Aadi Sub. On that same day, representatives of Leerink Partners and Nomura met via videoconference
in advance of the upcoming in-person site visit by representatives of Kaken Parent to Aadi’s New Jersey and California facilities.

On November 14, 2024, representatives of Bidder B contacted representatives of Leerink Partners to withdraw the previously delivered exclusivity request,
noting that Bidder B was not at that time prepared to improve its offer.

On November 14, 2024, representatives of Nomura met in-person with representatives of Aadi’s management team and Leerink Partners at Aadi’s New Jersey facilities.

On November 15, 2024, representatives of Kaken Parent and Nomura met in-person with representatives of Aadi